I am a professor of Biomedical Engineering at Duke University, and currently the Chair of the department. I work on genetically encoded biomaterials, drug delivery and point-of-care diagnostics. I have cofounded 5 companies — PhaseBio (NASDAQ: PHAS), Sentilus (acquired by Immucor in 2014), Gateway Bio, Isolere Bio and inSoma Bio,